Repare Therapeutics (NASDAQ:RPTX) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.12) by 166.67 percent. This is a 109.88 percent increase over losses of $(0.81) per share from the same period last year. The company reported quarterly sales of $11.620 million which beat the analyst consensus estimate of $7.500 million by 54.93 percent.